| Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease E De Pablo-Fernández, AJ Lees, JL Holton, TT Warner JAMA neurology 76 (4), 470-479, 2019 | 269 | 2019 |
| Association between diabetes and subsequent Parkinson disease: a record-linkage cohort study E De Pablo-Fernandez, R Goldacre, J Pakpoor, AJ Noyce, TT Warner Neurology 91 (2), e139-e142, 2018 | 223 | 2018 |
| Association of autonomic dysfunction with disease progression and survival in Parkinson disease E De Pablo-Fernandez, C Tur, T Revesz, AJ Lees, JL Holton, TT Warner JAMA neurology 74 (8), 970-976, 2017 | 205 | 2017 |
| Estimating the causal influence of body mass index on risk of Parkinson disease: a Mendelian randomisation study AJ Noyce, DA Kia, G Hemani, A Nicolas, TR Price, E De Pablo-Fernandez, ... PLoS medicine 14 (6), e1002314, 2017 | 163 | 2017 |
| The association between type 2 diabetes mellitus and Parkinson’s disease JLY Cheong, E de Pablo-Fernandez, T Foltynie, AJ Noyce Journal of Parkinson's disease 10 (3), 775-789, 2020 | 142 | 2020 |
| Neuroendocrine abnormalities in Parkinson's disease E De Pablo-Fernández, DP Breen, PM Bouloux, RA Barker, T Foltynie, ... Journal of Neurology, Neurosurgery & Psychiatry 88 (2), 176-185, 2017 | 96 | 2017 |
| Levodopa infusion improves impulsivity and dopamine dysregulation syndrome in Parkinson's disease MJ Catalán, E de Pablo‐Fernández, C Villanueva, S Fernández‐Diez, ... Movement Disorders 28 (14), 2007-2010, 2013 | 67 | 2013 |
| Association between Parkinson's disease and diabetes: Data from NEDICES study E De Pablo‐Fernandez, F Sierra‐Hidalgo, J Benito‐León, ... Acta Neurologica Scandinavica 136 (6), 732-736, 2017 | 60 | 2017 |
| A histologic study of the circadian system in Parkinson disease, multiple system atrophy, and progressive supranuclear palsy E De Pablo-Fernández, R Courtney, TT Warner, JL Holton JAMA neurology 75 (8), 1008-1012, 2018 | 58 | 2018 |
| A 30-unit hexanucleotide repeat expansion in C9orf72 induces pathological lesions with dipeptide-repeat proteins and RNA foci, but not TDP-43 inclusions and … P Gami, C Murray, L Schottlaender, C Bettencourt, E De Pablo Fernandez, ... Acta neuropathologica 130, 599-601, 2015 | 49 | 2015 |
| Clinical and imaging features of the room tilt illusion F Sierra-Hidalgo, E de Pablo-Fernández, A Herrero-San Martín, ... Journal of neurology 259, 2555-2564, 2012 | 49 | 2012 |
| Young‐onset multiple system atrophy: Clinical and pathological features A Batla, E De Pablo‐Fernandez, R Erro, M Reich, G Calandra‐Buonaura, ... Movement Disorders 33 (7), 1099-1107, 2018 | 44 | 2018 |
| Colonic transit, high-resolution anorectal manometry and MRI defecography study of constipation in Parkinson's disease E De Pablo-Fernández, V Passananti, N Zárate-López, A Emmanuel, ... Parkinsonism & Related Disorders 66, 195-201, 2019 | 35 | 2019 |
| Akinetic mutism induced by tacrolimus F Sierra-Hidalgo, A Martínez-Salio, S Moreno-García, ... Clinical Neuropharmacology 32 (5), 293-294, 2009 | 32 | 2009 |
| Hypothalamic α‐synuclein and its relation to weight loss and autonomic symptoms in Parkinson's disease E De Pablo‐Fernandez, R Courtney, JL Holton, TT Warner Movement Disorders 32 (2), 296-298, 2017 | 31 | 2017 |
| Identification of multiple system atrophy mimicking Parkinson’s disease or progressive supranuclear palsy Y Miki, E Tsushima, SC Foti, KM Strand, YT Asi, AK Yamamoto, ... Brain 144 (4), 1138-1151, 2021 | 29 | 2021 |
| Association of autonomic symptoms with disease progression and survival in progressive supranuclear palsy MCB Oliveira, H Ling, AJ Lees, JL Holton, E De Pablo-Fernandez, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (5), 555-561, 2019 | 28 | 2019 |
| Clinical diagnostic accuracy of Parkinson's disease: where do we stand? S Virameteekul, T Revesz, Z Jaunmuktane, TT Warner, ... Movement Disorders 38 (4), 558-566, 2023 | 27 | 2023 |
| Concomitant fragile X-associated tremor ataxia syndrome and Parkinson's disease: a clinicopathological report of two cases E De Pablo-Fernandez, KM Doherty, JL Holton, T Revesz, A Djamshidian, ... Journal of Neurology, Neurosurgery & Psychiatry 86 (8), 934-936, 2015 | 21 | 2015 |
| Faster disease progression in Parkinson’s disease with type 2 diabetes is not associated with increased α‐synuclein, tau, amyloid‐β or vascular pathology E de Pablo‐Fernández, R Courtney, A Rockliffe, S Gentleman, JL Holton, ... Neuropathology and Applied Neurobiology 47 (7), 1080-1091, 2021 | 19 | 2021 |
